Chemotherapy helps elderly patients with small cell lung cancer

Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC), these trials have predominantly compared different chemotherapy regimens rather than comparing chemotherapy to best supportive care. Some of them included chest radiation or prophylactic cranial irradiation. Moreover, many trials excluded elderly patients.

A recent looked at the benefit of chemotherapy on survival of elderly patients with SCLC in the community. This is the first large-scale analysis of chemotherapy use among patients with SCLC in the community setting.

In the October issue of the International Association for the Study of Lung Cancer's journal, the Journal of Thoracic Oncology (JTO), researchers conclude that chemotherapy is associated with a greater than 6-month improvement in median survival among elderly patients with SCLC, even in patients over the age of 80 years.

The researchers looked at data from 10,428 patients aged 65 years and older who were diagnosed with SCLC between 1992 and 2001. In this study, 67.1 percent received chemotherapy, most of whom (41.6 percent) received etoposide with or cisplatin with or without other agents.

The researchers found that one third of elderly patients with SCLC never receive chemotherapy, and one sixth are never referred to a medical oncologist, suggesting that chemotherapy is underused.

They conclude that, "despite methodological limitations, their study provides strong evidence that chemotherapy improves survival in elderly patients with SCLC."

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Protein may be key to cancer's deadly resurgences

1 hour ago

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently ...

US women's awareness of breast density varies

18 hours ago

Disparities in the level of awareness and knowledge of breast density exist among U.S. women, according to the results of a Mayo Clinic study published in the Journal of Clinical Oncology.

Study shows why some brain cancers resist treatment

18 hours ago

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.